265 related articles for article (PubMed ID: 24378952)
21. A rapid and simple UPLC method for serum vancomycin determination in pediatric patients undergoing continuous infusion or intermittent infusion of vancomycin.
Zhang M; Huang X; Yahui W; Shi C; Pei P; Yang J; Dong Q; Cui X
J Pharm Biomed Anal; 2019 Sep; 174():214-219. PubMed ID: 31176931
[TBL] [Abstract][Full Text] [Related]
22. Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial.
Gwee A; Cranswick N; Donath SM; Hunt R; Curtis N
BMJ Open; 2018 Nov; 8(11):e022603. PubMed ID: 30391914
[TBL] [Abstract][Full Text] [Related]
23. Continuous infusion of vancomycin in neonates.
Patel AD; Anand D; Lucas C; Thomson AH
Arch Dis Child; 2013 Jun; 98(6):478-9. PubMed ID: 23543265
[No Abstract] [Full Text] [Related]
24. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
Eiland LS; English TM; Eiland EH
Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion.
De Waele JJ; Danneels I; Depuydt P; Decruyenaere J; Bourgeois M; Hoste E
Int J Antimicrob Agents; 2013 May; 41(5):434-8. PubMed ID: 23410793
[TBL] [Abstract][Full Text] [Related]
26. A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
Jeurissen A; Sluyts I; Rutsaert R
Int J Antimicrob Agents; 2011 Jan; 37(1):75-7. PubMed ID: 21074374
[TBL] [Abstract][Full Text] [Related]
27. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
Saugel B; Nowack MC; Hapfelmeier A; Umgelter A; Schultheiss C; Thies P; Phillip V; Eyer F; Schmid RM; Huber W
J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
[TBL] [Abstract][Full Text] [Related]
28. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.
Beumier M; Roberts JA; Kabtouri H; Hites M; Cotton F; Wolff F; Lipman J; Jacobs F; Vincent JL; Taccone FS
J Antimicrob Chemother; 2013 Dec; 68(12):2859-65. PubMed ID: 23800905
[TBL] [Abstract][Full Text] [Related]
29. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK
J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a pediatric continuous-infusion vancomycin therapy guideline.
McKamy S; Chen T; Lee M; Ambrose PJ
Am J Health Syst Pharm; 2012 Dec; 69(23):2066-71. PubMed ID: 23172265
[TBL] [Abstract][Full Text] [Related]
31. Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients.
Colin PJ; Jonckheere S; Struys MMRF
Clin Pharmacokinet; 2018 Nov; 57(11):1435-1447. PubMed ID: 29512049
[TBL] [Abstract][Full Text] [Related]
32. Allometric versus consensus guideline dosing in achieving target vancomycin trough concentrations.
Brown ML; Hutchison AM; McAtee AM; Gaillard PR; Childress DT
Am J Health Syst Pharm; 2017 Jul; 74(14):1067-1075. PubMed ID: 28522643
[TBL] [Abstract][Full Text] [Related]
33. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
34. Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children.
Genuini M; Oualha M; Bouazza N; Moulin F; Treluyer JM; Lesage F; Renolleau S; Benaboud S
Pediatr Crit Care Med; 2018 Jun; 19(6):e263-e269. PubMed ID: 29394210
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial of a vancomycin loading dose in children.
Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB
Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340
[TBL] [Abstract][Full Text] [Related]
36. [Level of evidence for therapeutic drug monitoring of vancomycin].
Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Continuous Infusion Vancomycin Administration in a Critically Ill Trauma Population.
Bissell BD; Riggi G; Morrison C
J Intensive Care Med; 2020 Jun; 35(6):570-575. PubMed ID: 29642744
[TBL] [Abstract][Full Text] [Related]
38. [Dosage adjustment of vancomycin in continuous infusion in critically ill-patients].
Carricajo A; Forgeot A; Morel J; Auboyer C; Zeni F; Aubert G
Ann Fr Anesth Reanim; 2010 Jan; 29(1):55-7. PubMed ID: 20074899
[TBL] [Abstract][Full Text] [Related]
39. Continuous infusion vancomycin for treatment of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients.
Fung L
Ann Pharmacother; 2012 Oct; 46(10):e26. PubMed ID: 23032658
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and dose requirements of vancomycin in neonates.
Grimsley C; Thomson AH
Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F221-7. PubMed ID: 10525029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
